The Institute for Safe Medication Practices on Jan. 3 issued an alert warning pharmacists of potential error risks with Paxlovid, Pfizer’s COVID-19 antiviral pill regimen.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News